Lobbying

Medify Air's latest lobbying report covers Q1 2026, at under $5,000. Its first report covers Q4 2023; the issues it reports most are Health Issues and Economics/Economic Development.

Medify Air

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2023
The first quarter a report named it

Lobbying by quarter

Medify Air lobbying by quarter
Medify Air lobbying by quarter
QuarterAmountReports
Q4 2023$80K1
Q1 2024$80K2
Q2 2024$80K1
Q3 2024$80K1
Q4 2024$80K1
Q1 2025$80K3
Q2 2025$100K3
Q3 2025$30K2
Q4 2025$01
Q1 2026$01
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$415K · 13 reports
  • Economic development$95K · 3 reports
  • Budget and appropriations$35K · 2 reports
  • Trade$25K · 1 reports
  • Taxation$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • Health & Human Services, Dept of (HHS)6 reports
  • SENATE6 reports
  • U.S. Trade Representative (USTR)4 reports
  • Executive Office of the President (EOP)2 reports

Firms it paid

Firm
DB3$410K7 quarters
Baker Donelson Bearman Caldwell & Berkowitz$130K2 quarters
RBW Group$70K2 quarters
MS. Laura Lawlor$05 quarters

Former officials lobbying for it

Former position
THOMAS DASCHLEFormer United States SenatorQ1 2025

Lobbying reports

Filed by
08/07for Q1MS. Laura LawlorUnder $5,000
04/08for Q1MS. Laura LawlorUnder $5,000
01/16for Q4 2025MS. Laura LawlorUnder $5,000
25/11/07for Q3 2025MS. Laura LawlorUnder $5,000
25/11/06for Q3 2025DB3$30K
25/07/21for Q2 2025MS. Laura LawlorUnder $5,000
25/07/18for Q2 2025DB3$50K
25/07/18for Q2 2025RBW Group$50K
25/05/06for Q1 2025MS. Laura LawlorUnder $5,000
25/04/21for Q1 2025DB3$60K
25/04/12for Q1 2025RBW Group$20K
25/04/09for Q1 2025MS. Laura LawlorUnder $5,000
25/03/25for Q1 2025RBW GroupUnder $5,000
25/01/21for Q4 2024DB3$80K
24/10/21for Q3 2024DB3$80K
24/07/19for Q2 2024DB3$80K
24/04/20for Q1 2024DB3$30K
24/03/14for Q1 2024DB3Under $5,000
24/03/05for Q1 2024Baker Donelson Bearman Caldwell & Berkowitz$50K
24/01/21for Q4 2023Baker Donelson Bearman Caldwell & Berkowitz$80K